(19)
(11) EP 3 846 877 A2

(12)

(88) Date of publication A3:
30.04.2020

(43) Date of publication:
14.07.2021 Bulletin 2021/28

(21) Application number: 19857506.0

(22) Date of filing: 04.09.2019
(51) International Patent Classification (IPC): 
A61M 5/162(2006.01)
A61M 5/142(2006.01)
A61M 5/32(2006.01)
A61M 39/02(2006.01)
A61M 5/158(2006.01)
A61M 25/06(2006.01)
(86) International application number:
PCT/US2019/049518
(87) International publication number:
WO 2020/051211 (12.03.2020 Gazette 2020/11)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 04.09.2018 US 201862726715 P

(71) Applicants:
  • Biolark, Inc.
    San Diego CA 92130 (US)
  • Scott, Mark H.
    San Diego CA 92129 (US)
  • Bowman, Leif
    San Diego CA 92130 (US)
  • Foley, Nicholas John
    Edinburgh EHS 5PE (GB)

(72) Inventors:
  • SCOTT, Mark H.
    San Diego, CA 92129 (US)
  • BOWMAN, Leif
    San Diego, CA 92130 (US)
  • FOLEY, Nicholas John
    Edinburgh, EHS 5PE Scotland (GB)

(74) Representative: Schlee, Alexander Richard 
Schlee IP International Mauerkircherstraße 31
81679 München
81679 München (DE)

   


(54) EXTENDED USE INFUSION SET FOR MEDICAL USE